These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 14456743)
1. Immunological studies of anthrox. II. Levels of immunity against Bacillus anthracis obtained with protective antigen and live vaccine. KLEIN F; DEARMON IA; LINCOLN RE; MAHLANDT BG; FERNELIUS AL J Immunol; 1962 Jan; 88():15-9. PubMed ID: 14456743 [No Abstract] [Full Text] [Related]
2. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis. Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170 [TBL] [Abstract][Full Text] [Related]
3. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes. Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664 [TBL] [Abstract][Full Text] [Related]
4. Studies on immunity in anthrax. VI. Immunizing activity of protective antigen against various strains of Bacillus anthracis. AUERBACH S; WRIGHT GG J Immunol; 1955 Aug; 75(2):129-33. PubMed ID: 13242812 [No Abstract] [Full Text] [Related]
5. Elaboration of protective antigen of Bacillus anthracis under anaerobic conditions. WRIGHT GG; PUZISS M Nature; 1957 May; 179(4566):916-7. PubMed ID: 13430734 [No Abstract] [Full Text] [Related]
6. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits. Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139 [TBL] [Abstract][Full Text] [Related]
7. Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine. Marcus H; Danieli R; Epstein E; Velan B; Shafferman A; Reuveny S Infect Immun; 2004 Jun; 72(6):3471-7. PubMed ID: 15155654 [TBL] [Abstract][Full Text] [Related]
9. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions. Koehler SM; Buyuk F; Celebi O; Demiraslan H; Doganay M; Sahin M; Moehring J; Ndumnego OC; Otlu S; van Heerden H; Beyer W BMC Vet Res; 2017 Jul; 13(1):220. PubMed ID: 28701192 [TBL] [Abstract][Full Text] [Related]
10. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis]. Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model. Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738 [TBL] [Abstract][Full Text] [Related]
12. Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors. Wang HC; An HJ; Yu YZ; Xu Q Immunol Lett; 2015 Feb; 163(2):206-13. PubMed ID: 25102364 [TBL] [Abstract][Full Text] [Related]
13. Studies on immunity in anthrax. IX. Effect of variations in cultural conditions on elaboration of protective antigen by strains of Bacillus anthracis. WRIGHT GG; PUZISS M; NEELY WB J Bacteriol; 1962 Mar; 83(3):515-22. PubMed ID: 14008433 [TBL] [Abstract][Full Text] [Related]
14. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R. Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174 [TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanisms underlying bacillus anthracis infection at early stages and search for novel vaccines]. Stepanov AV; Marinin LI; Staritsyn NA; Noskov AN; Borovkova LV; Kravchenko TB Vestn Ross Akad Med Nauk; 1997; (6):16-20. PubMed ID: 9289272 [TBL] [Abstract][Full Text] [Related]
16. [Cloning and expression of determinants of Bacillus anthracis protective antigen in Escherichia coli, Bacillus subtilis, and Bacillus anthracis cells]. Tedikov VM; Dobritsa AP Mol Gen Mikrobiol Virusol; 1993; (2):13-6. PubMed ID: 8515744 [TBL] [Abstract][Full Text] [Related]
17. [Immunological properties of the preparations of the anti-anthrax antigen]. Shliakhov EN; Gruz EV; Burdenko TA; Moroz LV Zh Mikrobiol Epidemiol Immunobiol; 1977 Sep; (9):41-5. PubMed ID: 413294 [TBL] [Abstract][Full Text] [Related]
18. Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits. Weiss S; Kobiler D; Levy H; Marcus H; Pass A; Rothschild N; Altboum Z Infect Immun; 2006 Jan; 74(1):394-8. PubMed ID: 16368995 [TBL] [Abstract][Full Text] [Related]
20. Studies on infection with Bacillus anthracis; chemical and immunological properties of the protective antigen in crude extracts of skin lesions of B. anthracis. WATSON DW; CROMARTIE WJ J Infect Dis; 1947; 80(1):28-40. PubMed ID: 20283797 [No Abstract] [Full Text] [Related] [Next] [New Search]